Viewing Study NCT02566993


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-27 @ 11:43 PM
Study NCT ID: NCT02566993
Status: COMPLETED
Last Update Posted: 2021-10-28
First Post: 2015-09-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
Sponsor: PharmaMar
Organization: